Literature DB >> 18037558

Comparison of contrast-enhanced color Doppler imaging (CDI), computed tomography (CT), and magnetic resonance imaging (MRI) for the detection of crossing vessels in patients with ureteropelvic junction obstruction (UPJO).

Michael Mitterberger1, Germar M Pinggera, Richard Neururer, Reinhard Peschel, Daniela Colleselli, Friedrich Aigner, Johann Gradl, Georg Bartsch, Hannes Strasser, Leo Pallwein, Ferdinand Frauscher.   

Abstract

OBJECTIVE: To assess the use of contrast-enhanced color Doppler imaging (CDI), computed tomography (CT), and magnetic resonance imaging (MRI) for the detection of crossing vessels at the ureteropelvic junction (UPJ) in patients with ureteropelvic junction obstruction (UPJO).
MATERIALS AND METHODS: Forty-eight patients aged 18-69 yr (mean age, 52) who had been diagnosed with an UPJO on intravenous pyelography and diuretic renography were included. Contrast-enhanced CDI was performed by using both color Doppler frequency and color Doppler amplitude ("Power") modes. Spiral CT was performed by using a three-phase CT (arterial, venous, and excretory phases) allowing for CT angiography. MRI technique included dual-phase magnetic resonance angiography (arterial, venous) for the assessment of respective arteries and veins. The type (ie, arterial or venous) and position of the vessel relative to the UPJ (ie, anterior or posterior) were assessed. The CDI, CT, and MRI findings were correlated with the surgical findings at laparoscopic pyeloplasty.
RESULTS: Forty-four of 48 patients (92%) demonstrated crossing vessels at subsequent laparoscopy. Altogether a total of 60 vessels were detected. Contrast-enhanced CDI and MRI correctly detected all crossing vessels (accuracy, 100%), whereas CT missed four posterior crossing veins (accuracy, 93%).
CONCLUSION: Contrast-enhanced CDI is recommended as first-line imaging modality for the detection of crossing vessels in patients with UPJO.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18037558     DOI: 10.1016/j.eururo.2007.11.031

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  6 in total

Review 1.  Pediatric uroradiology: state of the art.

Authors:  Kassa Darge; J Damien Grattan-Smith; Michael Riccabona
Journal:  Pediatr Radiol       Date:  2010-04-21

2.  Non-contrast-enhanced MR angiography using time-spin labelling inversion pulse technique for detecting crossing renal vessels in children with symptomatic ureteropelvic junction obstruction: comparison with surgical findings.

Authors:  Nicolas Brucher; Julie Vial; Christiane Baunin; David Labarre; Olivier Meyrignac; Michel Juricic; Ourdia Bouali; Olivier Abbo; Philippe Galinier; Nicolas Sans
Journal:  Eur Radiol       Date:  2015-10-29       Impact factor: 5.315

3.  Current radiological techniques used to evaluate unilateral partial ureteral obstruction: an experimental rabbit study.

Authors:  Mehmet Yazıcı; Suleyman Celebi; Özgür Kuzdan; Hüseyin Koçan; Halil Suat Ayyıldız; İlkay Koray Bayrak; Meltem Ceyhan Bilgici; Oktay Yapıcı; Mehmet Kefeli; Ender Arıtürk
Journal:  Int Urol Nephrol       Date:  2015-05-06       Impact factor: 2.370

4.  Functional Magnetic Resonance Urography in Ureteropelvic Junction Obstruction: Proposal for a Pediatric Quantitative Score.

Authors:  Maria Beatrice Damasio; Fiammetta Sertorio; Michela Cing Yu Wong; Irene Campo; Marcello Carlucci; Luca Basso; Lorenzo Anfigeno; Monica Bodria; Angela Pistorio; Giorgio Piaggio; Gian Marco Ghiggeri; Girolamo Mattioli
Journal:  Front Pediatr       Date:  2022-06-16       Impact factor: 3.569

5.  Renal function recovery after laparosocopic pyeloplasty.

Authors:  Juan Gómez Rivas; Sergio Alonso Y Gregorio; María Portilla Eastmond; Angel Tabernero Gómez; Luis Hidalgo Togores; Jesús Díez Sebastián; Jesús Javier de la Peña Barthel
Journal:  Cent European J Urol       Date:  2014-06-23

6.  Percutaneous retropelvic endopyelotomy for treatment of ureteropelvic junction obstruction.

Authors:  Khalid M Alotaibi
Journal:  Urol Ann       Date:  2018 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.